Efficacy of the maxillary anterior segmental distraction osteogenesis in patients with cleft lip and palate Authors: Panjun Pu, Shanying Bao, Jianbo Gao, Yuhua Jiao, Feiyu Wang, Huaxiang Zhao, Yuxia Hou, Yalin Zhan Published: 2024 ABSTRACT BackgroundCleft lip and palate (CLP) is one of the most common birth defects worldwide. It typically results in significant maxillary dysplasia, causing severe oral function problems and substantially affecting the patient’s facial aesthetics. Maxillary anterior segmental distraction osteogenesis (MASDO) has gained popularity in recent years as an effective treatment for correcting maxillary dysplasia. However, the evaluation of its effectiveness in patients with CLP varies across different studies. Our research was aimed at providing evidence of the effects of MASDO among CLP patients.MethodsA meta-analysis covered Medline, Web of Science, Embase, Scopus, and Cochrane Library. Controlled clinical trial studies published before February 2024 and analyzed changes in maxillary cephalometric landmarks before and after MASDO among patients with maxillary hypoplasia and CLP were included.ResultsOur meta-analysis included 10 papers in total. One study was at low risk of bias, seven were at medium risk, and two were at serious risk. MASDO significantly increased the maxillary length. The mean SNA angle increased by 6.43° (95% CI, 4.11° to 8.74°) and A-McNamara rose by 7.29 mm (95% CI, 6.21 mm to 8.37 mm). The maxilla also showed a slight counterclockwise rotation; however, this reached no statistical significance. The mandibular position did not vary remarkably. Moreover, a significant increase in upper anterior tooth tipping and overjet, a decrease in overbite, and an improvement in nasolabial soft tissue were observed.ConclusionsMASDO might be a valid therapy option for CLP patients. It causes a significant increase in the maxillary length, anterior tooth crossbite, and nasolabial soft tissue were also greatly improved.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12903-024-05208-3. Background Maxillary hypoplasia has been a common symptom among patients suffering from cleft lip and palate (CLP) [1]. Additionally, they suffer from anterior or posterior tooth crossbite, severely crowded teeth, a rearward face on account of maxillary hypoplasia [2], dental arch collapse owing to alveolar cleft, and language disorders owing to velopharyngeal (VP) insufficiency [3]. The clinical symptoms above severely impact the facial aesthetics, mental health, oral function, and linguistic proficiency of CLP patients [4]. Le Fort I osteotomy (Le Fort I) is the most common treatment for maxillary hypoplasia among CLP patients, which anteriorly shifting the maxilla and correcting tooth crossbites and concave face [5]. However, this method only changes the position of the maxilla; the length of the maxilla does not change [6]. Therefore, there is still no space for the maxilla to align with the crowded teeth. It has also been noted that patients with CLP should not have a maxillary advancement distance > 6 mm. Recurrence is caused by the three-dimensional contraction and pulling of the scarring tissue, such as the lip, gingiva, and periosteum scars [7]. In addition, anterior maxilla displacement also issues within the soft palate forward and increases the region of the velopharyngeal (VP) port, which in turn causes postsurgical velopharyngeal insufficiency or aggravates the original velopharyngeal insufficiency [8]. If the distance the maxilla moves forward is greater, the risk will also be greater. Integrated with distraction osteogenesis, the later Le Fort I lengthened the maxilla and improved maxillary hypoplasia [9]. As it also extends neural, vascular, and soft tissues, the pulling of scarred tissues is decreased accordingly, reducing the relapse rate while increasing the level of maxillary growth [10]. However, this approach requires a traction hook to be extended from the face and a facebow to be worn for traction, which seriously affects the patient’s life [11]. Maxillary anterior segmental distraction osteogenesis (MASDO) is another way to increase the length of the maxilla. It involves a distraction segment that is made from the anterior part of the maxilla and advanced anterior maxilla forward,, but the posterior part of the maxilla is preserved [12] Moreover, MASDO places the distractor in the mouth, which not only increases the length of the maxilla, but also facilitates the alignment of crowded premolars, as the distraction site is mainly located in this location [13]. In addition, the velopharyngeal function was not affected because the position of the posterior maxillary segments and the velopharyngeal volume did not change [14] (Fig. 1). In order to assist clinicians in designing evidence-based therapy plans, our meta-analysis sums up the efficiency of MASDO in CLP patients. Fig. 1The clinical diagrams for the procedure of MASDO. (a) The palatal distractor was positioned on the palate and osteotomy was made between the maxillary first molar and the second premolar; (b) Linear advancement of the anterior part of the maxilla was achieved by activating the distractor positioned on the palate The clinical diagrams for the procedure of MASDO. (a) The palatal distractor was positioned on the palate and osteotomy was made between the maxillary first molar and the second premolar; (b) Linear advancement of the anterior part of the maxilla was achieved by activating the distractor positioned on the palate Methods Protocol and registration Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [15] were applied to this systemic review. The related protocol is registered in INPLASY (INPLASY202460073). Eligibility criteria The studies included complied with the inclusion criteria below: Clinical trial design: Only clinically controlled trials were retrospected, encompassing randomized controlled trials, non-randomized controlled trials, case-control researches, and cohort researches.Population: The researches involved CLP patients with maxillary hypoplasia.Intervention: The intervention was MASDO using an internal distractor.Comparison: The studies measured changes in the patient’s jaw, tooth and nasolabial soft tissue using cephalometric landmarks before and after MASDO.Outcome: The studies included nasolabial soft tissue measurements, dentoalveolar measurements, and facial skeletal measurements. Clinical trial design: Only clinically controlled trials were retrospected, encompassing randomized controlled trials, non-randomized controlled trials, case-control researches, and cohort researches. Clinical trial design: Only clinically controlled trials were retrospected, encompassing randomized controlled trials, non-randomized controlled trials, case-control researches, and cohort researches. Population: The researches involved CLP patients with maxillary hypoplasia. Population: The researches involved CLP patients with maxillary hypoplasia. Intervention: The intervention was MASDO using an internal distractor. Intervention: The intervention was MASDO using an internal distractor. Comparison: The studies measured changes in the patient’s jaw, tooth and nasolabial soft tissue using cephalometric landmarks before and after MASDO. Comparison: The studies measured changes in the patient’s jaw, tooth and nasolabial soft tissue using cephalometric landmarks before and after MASDO. Outcome: The studies included nasolabial soft tissue measurements, dentoalveolar measurements, and facial skeletal measurements. Outcome: The studies included nasolabial soft tissue measurements, dentoalveolar measurements, and facial skeletal measurements. The exclusion criteria were opinion papers, systemic reviews, reviews, case reports, case series, letters to editors, research on syndrome patients, animal research, and dual publications. Search strategy We retrieved the related research released before February 18, 2024, in Medline, Web of Science, Embase, Scopus, and Cochrane Library. The search adopted a combination of MeSH terms, free-text words, appropriate truncations and filters, with no language restriction. The search terms were attained by retrieving MEDLINE and changed according to other databases. Table S1 displays the explicit search tactic. Study selection and data extraction All researches were submitted to NoteExpress (version 20) and checked for duplicates. After excluding duplicate articles, three authors (P.P., S.B., and J.G.) screened titles and abstracts independently to remove research that did not meet the inclusion criteria. After that, full texts of the remaining research were rated. Risk of bias and quality assessment The risk of bias was rated via the Risk Of Bias in Non-randomized Studies–of Interventions (ROBINS-I) instrument. Besides, studies with an critical risk of bias were removed from in-depth analysis. P.P. and J.G. retrospected these researches. If there existed a distinction in opinions, the suggestion of a third reviewer was consulted. Statistical analysis 95% confidence intervals (CIs) and mean differences (MDs) were indispensable for analysis. I² statistic and p-value were used for evaluating heterogeneity. I² ≤ 50% and p ≥ 0.1 represented no or low heterogeneity, separately; besides, a fixed-effects model was adopted. I² > 50% and p < 0.1 represented moderate heterogeneity; additionally, subgroup analysis or a random-effects model was applied. I² > 75% and p < 0.1 represented high heterogeneity, and descriptive analysis was employed. All statistical analyses were performed through RevMan 5.4.1 software. Results Study selection and characteristics The screening and selecting processes are shown in Fig. 2. Database search included 1514 publications (MEDLINE N = 184, Web of Science N = 519, Embase N = 372, Scopus N = 420, and Cochrane Library N = 19). No other results were attained by manually searching reference lists. After removing duplicates, a total of 684 papers remained. With titles and abstracts screened, 41 papers were included for full-text analysis, of which 31 were removed based on the eligibility criteria. Of these removed studies, there were five studies where the control group was not pre-distracted, six studies where the experimental group was not post-distraction osteogenesis (DO), one study did not have a control group, 15 studies where DO was performed with rigid external distractors only or both rigid external distractors and internal distractors, three studies where measurement was not from cephalometrics, and one study where the treatment was secondary MASDO. The final analysis included the remaining 10 papers. Risk of bias within studies All 10 papers were rated for risk of bias to measure their strength of evidence. Based on this assessment, just one research was at low risk of bias, seven researches were at medium risk of bias, and two researches were at serious risk of bias (Fig. 3). According to the ROBINS-I tool, potential studies assessed with a critical risk of bias were excluded from further analysis and synthesis [16]. Therefore, no studies were removed from this meta-analysis because there were no critical-risk studies. Finally, ten studies were used for further meta analysis. Fig. 2The PRISMA flow chart of the research selection The PRISMA flow chart of the research selection Fig. 3The risk of bias evaluation in the individual researches with the ROBINS-I instrument The risk of bias evaluation in the individual researches with the ROBINS-I instrument Results of individual studies This analysis included 10 papers, encompassing four prospective studies, and six retrospective studies. Moreover, this research included 188 patients in total. The distraction rate varied between 0.5 mm/day and 1.0 mm/day, and all studies used lateral cephalograms for measurement and evaluation. Table 1 displays the features of the studies included. Table 1Main characteristics of the included studiesAuthorYearStudy designSample sizeAge(y)Appliance typeIntervention:DO protocolOutcomesKenji et al.(2023) [17]retrospective studyN = 1717.3(16–20)2 buccal distractors1.0 mm/dayStopping DO until ANB > 5.0° and/or overjet change > 5.0 mm.consolidation: 3 monthsSagittal and vertical variation of maxilla; Sagittal variation of mandible; Variation of relationship between maxilla and mandible; Change of overjet, overbite, nasolabial soft tissue.Chihiro et al.(2018) [18]retrospective studyN = 31(18 M, 13 F)19.2(14–26)Palatal or 2 buccal distractors1.0 mm/dayTo prevent unwanted upward movement of the segment, orthodontic elastic protraction from the facemask was used during distraction.Sagittal and vertical variation of maxilla; Variation of relationship between maxilla and mandible;Change of Overjet and nasolabial soft tissue.Liwen et al.(2023) [19]Retrospective studyN = 6(1 M, 5 F)15.2(14–16)Tooth-borne distractor (Hyrax) with miniscrew.1.0 mm/day.A total of 14 days distraction.consolidation: 3 months.Sagittal and vertical variation of maxilla; Sagittal variation of mandible; Variation of relationship between maxilla and mandible; Change of overjet, overbite, upper incisor position and nasolabial soft tissue.Sunil et al. (2011) [20]Prospective studyN = 14>12Tooth-borne palatal distractor0.72 mm/dayStopping DO until achieve a positive interincisal relation.Consolidation: 12–14 weeksVariation of ANS-PNS.Fethiye et al. (2014) [21]Prospective studyN = 19(10 M, 9 F)16.18 ± 3.10Tooth-borne distractor with Nance button to put forward the premaxilla.0.8 mm/dayStopping DO until overjet was corrected.Consolidation: 5 weeks.Sagittal and vertical variation of maxilla; Sagittal variation of mandible; Variation of relationship between maxilla and mandible; Change of overjet, overbite, upper incisor position and nasolabial soft tissue.Rodrigo et al.(2017) [27]Prospective studyN = 42118–25Tooth-borne distractor (Hyrax)1.0 mm/dayStopping DO after overjet was corrected.Consolidation: 8 weeks.Variation of overjet and OverbiteRachmiel et al.(2020) [22]Retrospective studyN = 42 (21 M, 21 F)16–29Internal distractor.1.0 mm/dayStopping DO until a slight over-correction of 2–3 mm.Consolidation: 16 weeksVariation of SNA and overjet.Xi et al.(2018) [23]Retrospective studyN = 42 (21 M, 21 F)14.2–30.52 buccal distractors1.0 mm/dayStopping DO until reaching a normal sagittal skeletal profile and normal anterior occlusion.Consolidation: 3 monthsSagittal variation of maxilla and change of overjet.Cheng et al.(2006) [24]Retrospective StudyN = 6 (4 M, 2 F)11.2(10–12)tooth-borne distractor (Hyrax)0.5 mm/dayDO was continued for 14 days.Consolidation: 3 months.Sagittal and vertical variation of maxilla; Change of nasolabial soft tissue.Rachmiel et al.(2004) [25]Prospective studyN = 712–182 buccal distractors1.0 mm/dayStopping DO until class I occlusion with slight overcorrection was achievedConsolidation: 8 weeks.Sagittal variation of maxilla; Vertical variation of mandible; Change of overjet, overbite, upper incisor position and nasolabial soft tissue. Table 1Main characteristics of the included studiesAuthorYearStudy designSample sizeAge(y)Appliance typeIntervention:DO protocolOutcomesKenji et al.(2023) [17]retrospective studyN = 1717.3(16–20)2 buccal distractors1.0 mm/dayStopping DO until ANB > 5.0° and/or overjet change > 5.0 mm.consolidation: 3 monthsSagittal and vertical variation of maxilla; Sagittal variation of mandible; Variation of relationship between maxilla and mandible; Change of overjet, overbite, nasolabial soft tissue.Chihiro et al.(2018) [18]retrospective studyN = 31(18 M, 13 F)19.2(14–26)Palatal or 2 buccal distractors1.0 mm/dayTo prevent unwanted upward movement of the segment, orthodontic elastic protraction from the facemask was used during distraction.Sagittal and vertical variation of maxilla; Variation of relationship between maxilla and mandible;Change of Overjet and nasolabial soft tissue.Liwen et al.(2023) [19]Retrospective studyN = 6(1 M, 5 F)15.2(14–16)Tooth-borne distractor (Hyrax) with miniscrew.1.0 mm/day.A total of 14 days distraction.consolidation: 3 months.Sagittal and vertical variation of maxilla; Sagittal variation of mandible; Variation of relationship between maxilla and mandible; Change of overjet, overbite, upper incisor position and nasolabial soft tissue.Sunil et al. (2011) [20]Prospective studyN = 14>12Tooth-borne palatal distractor0.72 mm/dayStopping DO until achieve a positive interincisal relation.Consolidation: 12–14 weeksVariation of ANS-PNS.Fethiye et al. (2014) [21]Prospective studyN = 19(10 M, 9 F)16.18 ± 3.10Tooth-borne distractor with Nance button to put forward the premaxilla.0.8 mm/dayStopping DO until overjet was corrected.Consolidation: 5 weeks.Sagittal and vertical variation of maxilla; Sagittal variation of mandible; Variation of relationship between maxilla and mandible; Change of overjet, overbite, upper incisor position and nasolabial soft tissue.Rodrigo et al.(2017) [27]Prospective studyN = 42118–25Tooth-borne distractor (Hyrax)1.0 mm/dayStopping DO after overjet was corrected.Consolidation: 8 weeks.Variation of overjet and OverbiteRachmiel et al.(2020) [22]Retrospective studyN = 42 (21 M, 21 F)16–29Internal distractor.1.0 mm/dayStopping DO until a slight over-correction of 2–3 mm.Consolidation: 16 weeksVariation of SNA and overjet.Xi et al.(2018) [23]Retrospective studyN = 42 (21 M, 21 F)14.2–30.52 buccal distractors1.0 mm/dayStopping DO until reaching a normal sagittal skeletal profile and normal anterior occlusion.Consolidation: 3 monthsSagittal variation of maxilla and change of overjet.Cheng et al.(2006) [24]Retrospective StudyN = 6 (4 M, 2 F)11.2(10–12)tooth-borne distractor (Hyrax)0.5 mm/dayDO was continued for 14 days.Consolidation: 3 months.Sagittal and vertical variation of maxilla; Change of nasolabial soft tissue.Rachmiel et al.(2004) [25]Prospective studyN = 712–182 buccal distractors1.0 mm/dayStopping DO until class I occlusion with slight overcorrection was achievedConsolidation: 8 weeks.Sagittal variation of maxilla; Vertical variation of mandible; Change of overjet, overbite, upper incisor position and nasolabial soft tissue. Main characteristics of the included studies Kenji et al. (2023) [17] 17.3 (16–20) 1.0 mm/day Stopping DO until ANB > 5.0° and/or overjet change > 5.0 mm. consolidation: 3 months Chihiro et al. (2018) [18] N = 31 (18 M, 13 F) 19.2 (14–26) 1.0 mm/day To prevent unwanted upward movement of the segment, orthodontic elastic protraction from the facemask was used during distraction. Sagittal and vertical variation of maxilla; Variation of relationship between maxilla and mandible; Change of Overjet and nasolabial soft tissue. Liwen et al. (2023) [19] N = 6 (1 M, 5 F) 15.2 (14–16) 1.0 mm/day. A total of 14 days distraction. consolidation: 3 months. 0.72 mm/day Stopping DO until achieve a positive interincisal relation. Consolidation: 12–14 weeks N = 19 (10 M, 9 F) 0.8 mm/day Stopping DO until overjet was corrected. Consolidation: 5 weeks. Rodrigo et al. (2017) [27] 21 18–25 1.0 mm/day Stopping DO after overjet was corrected. Consolidation: 8 weeks. Rachmiel et al. (2020) [22] 1.0 mm/day Stopping DO until a slight over-correction of 2–3 mm. Consolidation: 16 weeks Xi et al. (2018) [23] 1.0 mm/day Stopping DO until reaching a normal sagittal skeletal profile and normal anterior occlusion. Consolidation: 3 months Cheng et al. (2006) [24] 11.2 (10–12) 0.5 mm/day DO was continued for 14 days. Consolidation: 3 months. Rachmiel et al. (2004) [25] 1.0 mm/day Stopping DO until class I occlusion with slight overcorrection was achieved Consolidation: 8 weeks. Maxilla Changes in the maxilla were reported in nine articles [17–25]. Many different measurements have been used to reflect changes in the maxilla, of which SNA, A-McNamara, and ANS-PNS have been used to show the sagittal variation of the maxilla. The FH-ANS, FH-A, and SN/PP were used to show the vertical changes in the maxilla. The mean SNA ranged from 4.03° to 10.8°, the mean A-McNamara ranged from 3.94 mm to 11.83 mm, and the mean ANS-PNS ranged from 5.65 mm to 9.93 mm, all of which had statistically significant changes. The mean FH-ANS ranged from − 1.74 mm to 0.00 mm while the mean SN/PP ranged from − 2.03° to -0.16°, with statistically significant changes in two studies and no significant changes in another two. The mean FH-A ranged from − 1.97 mm to -0.90 mm, with statistically significant changes in two studies and no significant changes in one (Table S2). Mandible Mandibular variation was reported in three articles [17, 19, 21], and SNB was used to evaluate sagittal changes in the mandible. The mean SNB ranged from − 0.38° to 0.23°, with no statistically significant changes in all studies (Table S3). The ANB angle was used to show the variation in the relationship between the maxilla and mandible, reported in five articles [17–19, 21, 26]. The mean ANB ranged from 4.10° to 8.50°, with statistically significant changes in all studies (Table S4). Dento-alveolar changes Eight articles reported dental effects after MASDO among CLP patients [17–19, 21–23, 25, 27]. The average overjet varied between 4.70 mm and 13.66 mm, the average overbite changed between − 2.24 mm and − 0.61 mm, and the mean U1/SN ranged from 2.10° to 9.33°. The measurements in all the included studies were statistically different (Table S5). Soft tissue profile Six studies reported soft tissue effects [17–19, 21, 24, 25]. The mean nasolabial angle changes ranged from 4.83° to 13.53°, and the changes in four studies were statistically significant and 1 was not. The average Upper lip to E-line variation ranged from 3.22 mm to 7.50 mm, with statistically significant changes in all six studies (Table S6). Synthesis of results Owing to the distinctions between research in DO methods, distractors, patients, DO quantities, and duration, the meta-analysis uncovered different heterogeneity in the comprehensive results of numerous measurements. Heterogeneity was relatively low for ANB (I2 = 0%, p = 0.70), FH-ANS (I2 = 0%, p = 0.74), FH-A (I2 = 0%, p = 0.82), SNB (I2 = 0%, p = 0.98), SN/PP (I2 = 0%, p = 0.66), overbite (I2 = 27%, p = 0.25), and nasolabial angle (I2 = 0%, p = 0.78). Whereas, heterogeneity was excessively elevated for the ANS-PNS (I2 = 79%, p = 0.008), A-McNamara (I2 = 88%, p < 0.00001), SNA (I2 = 93%, p < 0.00001), overjet (I2 = 97%, p < 0.00001), Upper lip to E-line (I2 = 74%, p = 0.009), and U1/SN (I2 = 82%, p = 0.004). The SNA angle rose by 6.43° ± 2.59° (95% confidence coefficient, 4.11° to 8.74°) (Fig. 4a); A-McNamara rose by 7.29 mm ± 1.33 mm (95% confidence coefficient, 6.21 mm to 8.37 mm) (Fig. 4b); and ANS-PNS rose by 8.30 mm ± 2.25 mm (95% confidence coefficient, 5.44 mm to 11.15 mm) (Fig. 4c); which denoted a remarkable rise in the maxilla length. However, significant heterogeneity between the studies was noted for these three parameters. The FH-ANS declined by 0.82 mm ± 0.18 mm (95% confidence coefficient, -2.03 mm to 0.38 mm) (Fig. 5a); FH-A declined by 1.22 mm ± 0.28 mm (95% confidence coefficient, -2.73 mm to 0.29 mm) (Fig. 5b); additionally, the SN-PP angle declined by 0.97°± 0.25° (95% confidence coefficient, -2.12° to 0.18°) (Fig. 5c). The change of SNB reached no statistical significance (-0.20° ± 0.06°, p = 0.77) (Fig. 6a); besides, the ANB angle rose by 4.84° ± 1.73° (95% confidence coefficient, 4.01° to 5.66°, p < 0.00001) (Fig. 6b). The overjet rose by 9.20 mm ± 5.05 mm (95% confidence coefficient, 6.93 mm to 11.47 mm, p < 0.00001) (Fig. 7a); the U1/SN angle rose by 5.35° ± 1.37° (95% confidence coefficient, -0.10° to 10.80°, p < 0.00001) (Fig. 7b), and these two parameters had significant heterogeneity between the studies. The overbite declined by 2.09 mm ± 1.08 mm (95% confidence coefficient, -2.87 mm to -1.32 mm, p < 0.00001) (Fig. 7c); the nasolabial angle rose by 10.23° ± 1.15° (95% confidence coefficient, 8.27° to 12.19°, p < 0.00001) (Fig. 7d); additionally, the Upper lip to E-line rose by 4.87 mm ± 1.71 mm (95% 95% confidence coefficient, 2.84 mm to 6.90 mm, p < 0.00001) (Fig. 7e), and significant heterogeneity between the studies was noted for this parameter. Fig. 4Forest plot of maxilla sagittal change after MASDO. The outcomes were assessed: (a) SNA (°) increase after MASDO; (b) A-McNamara (mm) increase after MASDO; (c) ANS-PNS (mm) increase after MASDO; Forest plot of maxilla sagittal change after MASDO. The outcomes were assessed: (a) SNA (°) increase after MASDO; (b) A-McNamara (mm) increase after MASDO; (c) ANS-PNS (mm) increase after MASDO; Fig. 5Forest plot of maxilla vertical change after MASDO. The outcomes were assessed: (a) FH-ANS (mm) increase after MASDO; (b) FH-A (mm) increase after MASDO; (c) SN-PP (°) increase after MASDO Forest plot of maxilla vertical change after MASDO. The outcomes were assessed: (a) FH-ANS (mm) increase after MASDO; (b) FH-A (mm) increase after MASDO; (c) SN-PP (°) increase after MASDO Fig. 6Forest plot of SNB (°) and ANB (°) change after MASDO Forest plot of SNB (°) and ANB (°) change after MASDO Fig. 7Forest plot of tooth and nasolabial soft tissue change after MASDO. The outcomes were assessed: (a) Overjet (mm) increase after MASDO; (b) U1/SN (°) increase after MASDO; (c) Overbite (mm) increase after MASDO; (d) Nasolabial angle (°) increase after MASDO; (e) Upper lip to E-line (mm) increase after MASDO Forest plot of tooth and nasolabial soft tissue change after MASDO. The outcomes were assessed: (a) Overjet (mm) increase after MASDO; (b) U1/SN (°) increase after MASDO; (c) Overbite (mm) increase after MASDO; (d) Nasolabial angle (°) increase after MASDO; (e) Upper lip to E-line (mm) increase after MASDO Discussion Maxillary hypoplasia secondary to CLP presents a major clinical challenge. The aim of the present study was to assess the efficacy of the MASDO in patients with CLP. A total of 10 studies were included in the qualitative analysis after applying the inclusion criteria and risk of bias assessment. Owing to methodological differences between the articles, a meta-analysis was conducted on an exploratory basis for the main outcomes. Hypoplastic maxilla is considered a major issue among CLP patients. Le Fort I can correct the position of the maxilla but provides no space to solve dental crowding. Meanwhile, In Le Fort I, advancement of the posterior part of the maxilla complex can deteriorate velopharyngeal function in some patients [28]. MASDO following Le Fort I is another method to treat hypoplastic maxilla, and it has many advantages, such as reduced negative effects on velopharyngeal competence, greater advancement, and more long-term stable results [29–32]. For MASDO, Le Fort I osteotomy and vertical osteotomy were performed for the separation of the anterior segment of the maxilla, and then the intraoral distractor was positioned according to the surgical plan. Generally, after the latency period of 7 days, distraction was initiated. Distraction would be constant until reaching a normal sagittal skeletal profile and normal anterior occlusion as predetermined. When distraction was finished, the distraction devices were kept in situ for a consolidation period of 3–6 months [14]. Moreover, owing to the interdental osteotomy at the premolar region of the upper arch, MASDO can create an alveolar bone space for tooth alignment while simultaneously correcting maxillary hypoplasia [33, 34]. In this study, the results showed that after MASDO, the maxilla advanced effectively anterior. The SNA angle and A-McNamara increased by 4.58◦ and 5.35 mm, respectively. The increase of the length of palatal plane and upper arch gained sufficient space to align the crowded teeth. Furthermore, the surrounding soft tissue could simultaneously regenerate and moved forward based on bone advancement during MASDO, thereby improving the soft tissue profile. This meta-analysis also showed that nasolabial angle increased 10.23° and upper lip move forward 4.87 mm after MASDO. The phenomenon of counterclockwise rotation of the anterior segment has been reported in several clinical studies of MASDO. This rotation is likely caused by the design of the distractor and may contribute to relapse [18, 33, 35]. The results of present study showed that the maxilla had a slight counterclockwise rotation, but the difference was not statistically significant. To prevent unwanted upward movement of the anterior segment, it is recommended to use elastic intermaxillary traction or elastic protraction from the facemask during MASDO. MASDO was performed using different types of distractors, including palatal tooth-borne, palatal bone-borne, and buccal bone-borne distractors. In addition to differences in comfort, traumatic effects, and the requirement for a second surgery to remove the appliance, there are also differences in the distraction effectiveness of these appliances. The bone-borne intraoral appliances were introduced to provide effective distraction without dental effect, while the tooth-borne appliances would increase the load onto the anterior teeth then may exert a significant dental effect [28, 36]. The application of bilateral buccal bone-borne devices was first reported by Karakasis et al. [31], and using two buccal distraction devices created the possibility to allow asymmetrical elongation in MASDO. The bilateral rods must be nearly parallel to each other and to occlusal plane to ensure that they do not interfere with advancement, which means that achieving correct vectors on each side was challenging [37]. Of the studies included in the present meta-analysis, four used buccal bone-borne, one used palatal bone-borne, one used palatal tooth-borne with the Nance button, three used palatal tooth-borne, and one used bone-borne or tooth-borne. Therefore, the type of distractor may be one of the factors contributing to the heterogeneity in distraction efficacy. The limitations of the present study include the lack of a detailed analysis of velopharyngeal function, relapse rate, and psychosocial repercussions. In the future, studies with larger sample sizes, multi-institutional analyses, longer follow-up durations, and a detailed analysis of effectiveness and stability are required. Conclusions MASDO might be a valid therapy option for CLP patients. It causes a significant increase in the maxillary length, anterior tooth crossbite, and nasolabial soft tissue were also greatly improved. Electronic supplementary material Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1